Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03310905 · ClinicalTrials.gov registry record · NA
Abdominal Wall Transplant
A NA study of Transplant;Failure,Kidney and Transplant; Failure, Liver, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT03310905: Recruiting NA study of Transplant;Failure,Kidney and Transplant; Failure, Liver, sponsored by Duke University.
NCT03310905 is a NA study of Transplant;Failure,Kidney and Transplant; Failure, Liver that is actively recruiting participants, run by Duke University. The registered enrollment target is 5 participants, below the 223-participant average among 8 other Transplant;Failure,Kidney trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03310905, a NA study of Transplant;Failure,Kidney and Transplant; Failure, Liver, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this protocol is to determine the safety and efficacy of abdominal wall transplantation as a treatment for the reconstruction of abdominal wall defects. Abdominal wall transplantation may be performed alone or in combination with another transplant.
Conditions Studied
Interventions
- PROCEDURE Abdominal Wall Transplant with another solid organ transplant
- PROCEDURE Abdominal Wall Transplant alone
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2028-06-01 |
| Phase | NA |
What NCT03310905 shows while recruiting
NCT03310905 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 223-participant average among 8 other Transplant;Failure,Kidney trials with a reported enrollment target (98% lower).
The record links to 7 conditions, with Transplant;Failure,Kidney appearing as the primary indexed condition, and to 2 interventions - of which Abdominal Wall Transplant with another solid organ transplant is the first listed.
NCT03310905 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03310905 about?
NCT03310905 is a clinical study titled "Abdominal Wall Transplant". The purpose of this protocol is to determine the safety and efficacy of abdominal wall transplantation as a treatment for the reconstruction of abdominal wall defects. Abdominal wall transplantation may be performed alone or in combination with another transplant.
What is the current status of trial NCT03310905?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2018-05-01. Estimated completion is 2028-06-01.
What conditions does trial NCT03310905 study?
This clinical trial studies the following conditions: Transplant;Failure,Kidney, Transplant; Failure, Liver, Abdominal Wall Hernia, Transplant; Failure, Bowel, Abdominal Wall Defect.
What interventions are being tested in trial NCT03310905?
The interventions under investigation include: Abdominal Wall Transplant with another solid organ transplant (PROCEDURE), Abdominal Wall Transplant alone (PROCEDURE).
Who is sponsoring clinical trial NCT03310905?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03310905 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Transplant;Failure,Kidney
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03310905's enrollment target sits among peer trials
5 9th of 8 the lowest of 8 other Transplant;Failure,Kidney trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Transplant;Failure,Kidney trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
-
Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
RECRUITING · NA
-
Oral Paricalcitol in Kidney Transplant Recipients
COMPLETED · NA
-
TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
RECRUITING · Phase 4
-
Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
ACTIVE NOT RECRUITING · Phase 1
-
Quality of Life in Pre and Post Renal Transplant in Hispanic and Non-Hispanic Recipients
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI